stockrowAlamar Biosciences, Inc. (ALMR) vs CONMED Corporation (CNMD)
- Alamar Biosciences, Inc. ALMR 27.54 +2.34%
- CONMED Corporation CNMD 51.75 −2.04%
Alamar Biosciences, Inc. and CONMED Corporation are both Medical Devices companies. Alamar Biosciences, Inc. is the larger, with a market value of $1.9B against $1.6B — 1.2× the size. Alamar Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; CONMED Corporation trades at 21.7×. CONMED Corporation has the higher net margin (5.36% vs −52.2%) and the higher return on invested capital (4.64% vs −10.1%). Across the 16 metrics below, CONMED Corporation leads on 11 and Alamar Biosciences, Inc. on 5.
Valuation
Profitability
| Metric | ALMR | CNMD | Medical Devices median |
|---|---|---|---|
| Gross margin | 58.38% | 57.57% | 57.76% |
| Operating margin | (46.53%) | 9.90% | (15.07%) |
| Net margin | (52.19%) | 5.36% | (14.45%) |
| Free cash flow margin | (104.68%) | 9.69% | (3.88%) |
| Return on equity | (64.46%) | 7.10% | (10.35%) |
| Return on assets | (20.81%) | 3.17% | (17.26%) |
| Return on invested capital | (10.07%) | 4.64% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack